MAOB and Dyskinesia: When patients experience wearing-off, the dose or number of administrations of levodopa may be adjusted, or levodopa adjunctive drugs such as a dopamine agonist (DA), monoamine oxidase B (MAO-B) inhibitor, or catechol-O-methyltransferase (COMT) inhibitor are added to avoid dyskinesia.